# Effects of Abrocitinib Treatment on Skin Barrier Function

> **NCT05140239** · — · ACTIVE_NOT_RECRUITING · sponsor: **Prof. Dr. Stephan Weidinger** · enrollment: 20 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT05140239
- **Lead sponsor:** Prof. Dr. Stephan Weidinger
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-09-01
- **Primary completion:** 2024-09-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05140239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05140239, "Effects of Abrocitinib Treatment on Skin Barrier Function". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05140239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*